Perrigo consumer self-care president to retireJeff Needham, Perrigo executive vice president and president of consumer self-care Americas, will be retiring effective Sept. 30. He will be succeeded by current Ranir CEO Rich Sorota. BioMotiv, Bristol-Myers Squibb launch Anteros PharmaceuticalsAnteros Pharmaceuticals will focus on inflammatory diseases. Cardinal Health posts 5% revenue growth in Q2 Cardinal Health's second-quarter revenue for the pharmaceutical segment was $35.7 billion, a hike of 6% from the same period last year. Ashworth named Walgreens president Richard Ashworth, who has been with Walgreens for nearly three decades, is taking the helm of the retailer. McKesson sees revenue gains in Q3 McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion. Towa closes acquisition of Esteve's generics division Breckenridge is among the companies included in the acquisition. CVS Health slims down its board CVS Health’s board will transition from 16 to 13 directors, with two longtime directors retiring and the former CEO of Aetna departing after the company's annual meeting. Global sales of branded generics are expected to grow by 8% Antihypertensives are expected to be the best-selling global branded generics category. Estée Lauder shuffles global leadership team Estée Lauder has appointed several brand presidents across its La Mer, MAC Cosmetics, Le Labo, Dr. Jart+ and Do The Right Thing brands. Par launches authorized generic Carafate Sucralfate oral suspension had a market value of roughly $285 million for the 12 months ended Nov. 30, 2019, according to IQVIA. First Previous 115 116 117 118 119 Next Last
